Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
84.40%
↑ 1616% vs avg
Percentile
P100
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-5.57%
Historical baseline
PeriodValue
Q4 202584.40%
Q3 20256.29%
Q2 20256.55%
Q1 2025-22.74%
Q4 20241.18%
Q3 2024-34.23%
Q2 202422.17%
Q1 2024-19.50%
Q4 2023-6.73%
Q3 20231.98%
Q2 202327.06%
Q1 2023-64.47%
Q4 2022-93.41%
Q3 202250.26%
Q2 2022-70.72%
Q1 2022-15.61%
Q4 20214.62%
Q3 2021-9.48%
Q2 202121.05%
Q1 20210.00%